Costs of hospital-associated care for patients with juvenile idiopathic arthritis in the Dutch healthcare system.

Hospital care costs of JIA vary substantially between individuals, between subtypes, and over the treatment course. The highest annual costs were for systemic JIA, primarily attributable to medication (i.e. biologicals). Costs of other hospital-associated care were comparable regardless of subtype.